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Summary The government in England has supported the production of a number of
reports on services for people with epilepsy over the last three or four decades but
these have not come with any promise to provide resources or to achieve change. In
recent years, the voluntary agencies have worked with government in undertaking
some very worthwhile initiatives. The publication of the audit on epilepsy-related
deaths and the commitment of the Chief Medical Ofﬁcer have led to the produc-
tion of an Action Plan entitled ‘‘Improving Services for People with Epilepsy’’. This
Plan covers many of the key issues in the management of epilepsy and is seen as
an important ﬁrst step towards actual improvement of services. There is certainly a
consensus that improvement is necessary with too many people receiving inadequate
diagnosis and management leading, in some cases, to avoidable morbidity and mor-
tality. A critical overview of the Action Plan and a suggested 10-point model Action
Plan are presented. Whether the further necessary steps following the Department
of Health Action Plan will be taken, remains to be seen. All those responsible for the
management and wellbeing of people with epilepsy very much hope that the required
measures will be taken to ensure signiﬁcant long-term improvements in services.
© 2004 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
Preamble
A caring member of parliament with no particular
medical knowledge was walking down the street,
not far from the Houses of Parliament in Westmin-
ster, London, when he came across someone having
a seizure. He did not know what to do. He called a
policeman. The policeman did not appear to know
what to do. The member of parliament felt that
this situation could not be right. The result was that
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he inspired other members of parliament to join
with him to form an all-party group on epilepsy. The
founder member of this group was John Battle MP.
The group then continued its very valuable work un-
der the leadership of Stephen Twigg MP and has re-
cently been led by Baroness Gould of Potternewton.
Several questions about epilepsy have been asked
in the House of Commons in recent years and the
all-party group has become a very positive inﬂuence
on epilepsy policy.
A young woman was in a loving relationship
with a man who had epilepsy. Her partner died
unexpectedly. She was appalled by the ignorance
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surrounding the condition of sudden unexplained
death in epilepsy (SUDEP). It became apparent that
most doctors did not seem to know much about the
condition or may not have heard of it at all. What
action did she take? She became the founder of a
highly active charity group: ‘‘Epilepsy Bereaved?’’1
This charity not only provides support to members
of the family of any person with epilepsy who has
died but has also implemented a number of valu-
able initiatives. As a result, research into SUDEP
has increased markedly in the UK, an extensive
audit report2 has been produced, revealing infor-
mation that some might consider to be shocking,
and a group of people interested in the provision
of epilepsy services has met with the Chief Medi-
cal Ofﬁcer. The Chief Medical Ofﬁcer’s plan3 also
highlighted the problems of SUDEP and the need
to improve epilepsy services. As a result of the
undertaking by the Chief Medical Ofﬁcer, govern-
ment had to respond. The response is ‘‘Improving
Services for People with Epilepsy: Department of
Health Action Plan in Response to the National Clin-
ical Audit of Epilepsy-Related Death’’.4 The Chief
Medical Ofﬁcer has written to NHS Trust Chief Ex-
ecutives, Primary Care Trust Professional Executive
Chairs and Strategic Health Authority Chief Execu-
tives drawing attention to the Plan.5 However, will
this ‘‘Action Plan’’ make any difference to services
for people with epilepsy?
The aim of this paper is not only to discuss the
question of whether the Action Plan is likely to
make a difference. Other issues also need to be ad-
dressed. These include the following:
• Providing adequate training for professionals,
not only those in heath care but also those in
other relevant caring professions and those in
the teaching profession
• Educating the public
• Providing the patient with clear and full informa-
tion on epilepsy, treatment and risks
• Improving the quality of diagnosis
• Providing adequate targeted investigation and
treatment, including treatment of status epilep-
ticus
• Supporting the psychological wellbeing of pa-
tients and families
• Making available expert attention for special
groups, such as children, women of childbearing
age, pregnant women, the elderly and people
with learning disability or psychiatric disturbance
• Providing adequate epilepsy neurosurgery ser-
vices for both adults and children
• Setting clear standards for epilepsy services, us-
ing limited resources to best advantage and es-
tablishing good resource planning
• Ensuring that there are good epilepsy services
throughout the country instead of the current
patchy provision
Clear government targets for epilepsy services
are needed because, in our society, these become
the priorities for resources.
Are there other reports that might provide a
model for an Action Plan? How does the UK compare
with other western countries? How should such ini-
tiatives be viewed in terms of the worldwide needs
of people with epilepsy?
An overview of the Action Plan
The document is broken into four sections. These
will be discussed in turn, using the same headings
and numbering as in the original report, except for
the addition of the numbering I—IV before the main
headings of the Action Plan to distinguish them from
other headings in this paper.
I. Introduction
(1) The introduction states that epilepsy is
the most common chronic disabling con-
dition of the nervous system affecting
around 380,000 people in England, of
which almost 800 die yearly as a result
of the epilepsy.
(2) Reference ismade to the National Clinical
Audit of Epilepsy-Related Death (SUDEP)
published in May 2002 (www.sudep.org
and www.nice.org.uk/pdf/epilepsyre-
port.pdf).2 It acknowledges the impor-
tant role played by the voluntary organi-
sation, Epilepsy Bereaved?,1 in managing
the audit.
(3) Reference is made to the Chief Medical
Ofﬁcer’s report. (www.doh.gov.uk/cmo/
annualreport2001/index.htm).3 This is
an excellent report with speciﬁc aims re-
lating to epilepsy services, including the
requirement that: ‘‘Within 3 months of
completion of the National Sentinel Au-
dit of Sudden Death in Epilepsy an Action
Plan should be in place to cut the level
of preventable deaths from this cause’’.
The Action Plan was in response to this.
The Plan states the hope that it will start
a process of improving awareness and
understanding of SUDEP and will lead to
improved care and services for people
with epilepsy.
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(4 and 5) Cross references are made to other doc-
uments available on the web but some
of these had not been prepared at the
time the Action Plan was produced, no-
tably the National Institute for Clinical
Excellence6 report on newer antiepilep-
tic drugs and the National Service Frame-
work for long-term conditions.7
II. Pathology and post-mortem investigations
The following ﬁndings from the audit are quoted:
• There are no speciﬁc guidelines for the investi-
gation of epilepsy-speciﬁc death.
• Death certiﬁcation was of poor quality.
• Two-thirds of pathologists indicated that they
had no mechanism to inform relatives about
post-mortem results.
• Little evidence of contact with relatives after
death, with only 10% of families contacted by spe-
cialists and 7% by a GP.
(6) The point about poor death certiﬁcation was
made some years ago in a letter to the Lancet.8
However, it is worth emphasising because the
situation continues. The other three points are
clearly of considerable importance.
(a) Attention is drawn to the Royal College of
Pathologists’ website (www.rcpath.org)9
which is said to include a section on the
neuropathology and epilepsy in Guidelines
on Good Autopsy Practice. The author could
not ﬁnd this document on the website but,
with the assistance of the Royal College,
discovered that there was probably an er-
ror in the title; the publication is on the
website as Guidelines on Autopsy Practice.
There is a small section on epilepsy which
makes worthwhile reading, apart from the
fact that there is a rather vague reference
to ‘‘status epilepticus’’, which is not de-
ﬁned. This is unfortunate since ‘‘status
epilepticus’’ has often incorrectly been
recorded as the certiﬁed cause of death in
people with epilepsy when there has been
no evidence of this. Many of these patients
probably had SUDEP.
It is interesting to note that a search
for the terms ‘‘epilepsy’’ or ‘‘epileptic’’
or ‘‘epilepsies’’ on the Royal College of
Pathologists’ website reveals four other
documents. One of these states that the
College is working with the National Insti-
tute of Clinical Excellence on the diagnosis
and management of epilepsy in children
and adults. A further reference, ironically,
is to the threats and challenges to neu-
ropathology in the UK. However, the de-
tails of this document are available only
to Fellows or Members of the College. The
third reference was not relevant and the
fourth reference was, it is pleasing to note,
on the National Sentinel Clinical Audit of
Epilepsy-Related Death.
(b) The next reference in the Action Plan, to
the ‘‘removal, retention and use of hu-
man organs and tissue’’ is regrettable.10
Although this document indicates very nec-
essary improvements in practice, the way
in which the previous Secretary of State
for Health and the media handled the
question of organ retention, referring to
it as ‘‘a scandal’’ instead of referring to
it as practice that needed to be updated,
has contributed to the current critical
shortage of pathologists; this is particu-
larly true of paediatric neuropathologists.
The implication is that paediatric epilepsy
neuropathology will be greatly hindered
in the UK for many years to come. The
reference to the Government document
Human Bodies, Human Choices, July 2002
(www.doh.gov.uk/tissue/choices.pdf)11
does contain the worthwhile statement
that there should be ‘‘improved support
and advice to families at the time of be-
reavement, including the development of
the role of bereavement advisers within
every NHS trust’’.
(c) A particularly positive subsection, again
mentioning support for the bereaved, is
the reference to the fact that the Depart-
ment of Health has been contributing to
the coroners’ review consultation docu-
ment, which was expected to recommend
the following.
• A more modern system for certifying and
investigating deaths, including investigation
of premature medical deaths, such as from
epilepsy.
• Support for the bereavedwhich is at the heart
of a reformed inquest process, with explicit
service standards for the provision of infor-
mation, advice on bereavement counselling,
and the involvement of families in key as-
pects of any post-mortem examination deci-
sions.
The outcome of these ‘‘expected recommen-
dations’’ is awaited with great interest.
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III. Improving care, management and
treatment of epilepsy
The ﬁndings of the National Clinical Audit of
Epilepsy-Related Death on quality of care received
by individuals in general practice and hospitals
make quite shocking reading. The authors of the
audit concluded that in hospitals 54% of adults had
inadequate care, which led to the conclusion that
39% of adult deaths were considered potentially
or probably avoidable. The main deﬁciencies iden-
tiﬁed were: inadequate access to specialist care
(35%), inadequate drug management (20%), lack
of appropriate investigations (13%), no evidence
of a package of care (5%), inadequate recording
of patients’ histories (5%), adults with learning
disabilities ‘‘lost’’ in transfer from child to adult
services (6%) and one or more major clinical man-
agement errors (5%). 77% of children had inade-
quate care, which led to the conclusion that 59%
of deaths in children were potentially or probably
avoidable. The main deﬁciencies identiﬁed were:
inadequate drug management (45%), inadequate
access to specialist care (36%) and inadequate in-
vestigations (32%). In primary care management
the main problems identiﬁed were: lack of timely
access to skilled specialists, sparse evidence of
structured management plans, triggers for referral
sometimes being missed and professional commu-
nication failures. Although criteria for adequate
care and management are open to debate, these
results are, nevertheless, quite grim in that they
suggest that 39% of adult deaths and 59% of child-
hood deaths were potentially or probably avoid-
able. The Department of Health might reasonably
be expected to make a robust response to these
ﬁgures.
(7) In the Action Plan there is a subheading, at this
point: ‘‘Department of Health Response–—How
We Will Make Improvements’’. However, this
section is full of ‘‘soft’’ terminology: ‘‘we will
engage’’, ‘‘suggest’’, ‘‘refer them to’’, ‘‘we
will discuss with’’, ‘‘liaising with’’, instead of
using words such as ‘‘require’’, ‘‘implement’’,
‘‘set clear standards’’ or ‘‘expect speciﬁc tar-
gets to be met’’.
(a) The Action Plan states that the Depart-
ment of Health will engage with NHS
and Primary Care Trusts, and Strategic
Health Authorities to suggest they re-
view local epilepsy services. They will be
referred to the Joint Epilepsy Council’s
National Statement of Good Practice
(www.jointepilepsycouncil.org.uk).12 Why
does the Action Plan use the wording ‘‘we
will refer them’’ instead of stating ‘‘we
shall expect them to follow’’? This is one of
several examples of very weak wording in
the document. The Joint Epilepsy Council’s
National Statement of Good Practice is an
extensive document with useful and spe-
ciﬁc recommendations. It might be argued
that the Action Plan could have drawn more
heavily on this document and on other re-
ports that have been published within the
UK in recent years, notably the high quality
Scottish Intercollegiate Guidelines Network
(SIGN) document ‘‘Diagnosis and Manage-
ment of Epilepsy in Adults’’.13 The Depart-
ment of Health also undertakes to ‘‘link
this with’’ the Modernisation Agency’s Na-
tional Primary and Care Trusts Develop-
ment Plan (NaTPaCT) competency frame-
work website (www.natpact.nhs.uk).14 At
the time of writing of this paper the NaT-
PaCT website makes almost no reference
to epilepsy apart from having a link to the
epilepsy plan with the statement: ‘‘PCTs
urged to carry out local epilepsy service
reviews as part of drive to cut sudden
deaths’’.
It should be noted, in this context, that
the production of guidelines for the ap-
pointment of general practitioners with
a special interest in the delivery of clin-
ical epilepsy services15 represents a very
positive move forward.
(b) The Action Plan undertakes to discuss with
the Modernisation Agency a range of ini-
tiatives aimed at improving neurology ser-
vices, including epilepsy. £1.2 million is al-
located for investment in a 2-year project
to improve quality and access in neurology
services, starting in April 2003. It is pleas-
ing to note that resources are being com-
mitted but it is difﬁcult to see how this
sum of money could be spent in a way that
will actually improve services. With approx-
imately 380,000 people who have epilepsy
in the country, this sum represents less than
£4 per patient. Some speciﬁc indication of
how the money will be spent might have
been helpful.
The statement that there will be liaison
with neurology professional organisations
and the Royal College of General Practi-
tioners to produce the speciﬁc framework
to help develop more general practitioners
and nurses with a special interest in neu-
rology is very much welcomed but again,
this statement is rather vague.
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(c) Reference is made in this section to the
Children’s National Service Framework.16
Many dedicated professionals are, at the
time of writing this paper, putting an enor-
mous amount of effort into producing a
good Children’s NSF but at this stage it is
not at all clear what will be included in the
ﬁnal documentation.
(i) The Action Plan does state that the Dis-
abled Child module of the Children’s NSF
will set generic standards aiming to im-
prove multi-agency support for disabled
children, including those with epilepsy.
It will be interesting to see how this
translates into practice. The Action Plan
gives no indication of how this might
occur.
(ii) Reference is made to the Maternity mod-
ule of the NSF, pointing out that nine
epilepsy-related deaths were identiﬁed in
the report on conﬁdential enquiries into
maternal deaths in the United Kingdom:
Why Mothers Die 1997—1999.17 It should
be noted that the Action Plan gives an
out-of-date website at this point. The
correct website is www.cemach.org.uk.
Why Mothers Die is a lengthy, detailed,
high-quality report with over 30 ref-
erences to epilepsy. The comments
about epilepsy safety are very rele-
vant. For example, it rightly draws
attention to the unnecessary deaths
of pregnant women with epilepsy by
drowning in the bath and also considers
SUDEP.
(d) The website on the NSF for Long-term
Conditions (www.doh.gov.uk/nsf/longterm.
htm)7 has a number of links, including
those to the working groups. One of the
links quotes the Health Minister, Jacqui
Smith, as stating, in June 2002, that the
NSF for Long-Term Conditions would have
‘‘a particular focus on the needs of peo-
ple with neurological conditions and brain
and spinal injury’’. It also comments that
the previous Secretary of State, Alan Mil-
burn, had announced in February 2001 that
it would cover services for people with
epilepsy, multiple sclerosis, Parkinson’s
disease, motor neurone disease as well as
brain and spinal injury. It will be interest-
ing to see what the ﬁnal contribution on
epilepsy will be.
(e) The Department of Health strategy Phar-
macy in the Future (2000) is mentioned in
the Action Plan. The website is www.doh.
gov.uk/pharmacyfuture/index.htm.18 How-
ever, ‘‘epilepsy’’, ‘‘antiepileptic’’ and
‘‘anticonvulsant’’ could not be found in
this document, which refers to general
principles.
(i) The Action Plan states that clinicians
involved in the epilepsy audit will be
invited to participate in the future
Medicine Management Services (MMS)
Programme collaborative workshops
for PCTs. It is not at all clear what
the impact of this would be. Good
guidelines for pharmaceutical man-
agement might provide a ﬁrm way
forward in this regard. The website
is www.doh.gov.uk/pharmacyfuture/
medicinesmanagement.htm.19 It states
that local pilot sites will need to deﬁne
their own speciﬁc local and measurable
targets within which they will be able
to demonstrate ﬁve listed goals includ-
ing improved patient satisfaction with
medicine management services provided.
These valuable goals are all very gen-
eral and could apply to any disease or
disorder.
(ii) Reference is also made to Task Force
on Medicines Partnership, a 2-year ini-
tiative aiming to help patients beneﬁt
from their medication by exploring how
to improve partnership between patients
and health care professionals. It is said
that epilepsy will be prioritised in these
projects and that the task force will pilot
professional development for neurolo-
gists and others involved in epilepsy in
relation to medicines. It will also under-
take to look at individual patient expe-
rience. These initiatives appear to be
very worthwhile, although it is difﬁcult,
at this stage, to estimate what the im-
pact will be. Information on the Task
Force on Medicines Partnership can be
found at the website www.medicines-
partnership.org.20 This discusses the tran-
sition in concept from compliance to
concordance. The latter implies a part-
nership in which the patient understands
the reasons for the prescription of the
medication and works together with the
prescriber rather than simply comply-
ing with instructions. Again, these are
very laudable aims but they are gen-
eral and do not apply speciﬁcally only to
epilepsy.
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(f) The National Institute for Clinical Excel-
lence (NICE)6 is currently examining the
role of the newer antiepileptic drugs in the
treatment of epilepsy. The current author
has read the initial drafts both for adults
and children. Regrettably the emerging
documentation is not encouraging and
leaves the clinician with the impression
that the purpose of the exercise is to limit
costs rather than to provide best standards
of antiepileptic drug treatment. It should
be noted, however, that these comments
have been made on the emerging documen-
tation and not on the ﬁnal report. It is to
be hoped that by the time the ﬁnal report
is prepared, many of the reservations that
experienced clinicians have had about the
emerging documentation will have been
resolved.
(g) This section acknowledges that workforce
recruitment, education and training issues
are important. It comments that a group
to look at workforce and training issues for
the Long-Term Conditions NSF7 has already
been formed but there is no further infor-
mation other than a statement that there
is a plan to support the NSF over its 10-year
implementation period.
(h) The importance of neuroimaging is ac-
knowledged and there is a statement that
by the end of 2004 central programmes will
have provided a total of approximately one
hundred MRI scanners and two hundred CT
scanners for the NHS. These neuroimag-
ing facilities are much needed, although it
should be noted that CT scanning is of very
much less value than MRI scanning in the
investigation of epilepsy. The Action Plan
states the target date for having provided
these scanners but it does not state the
start date, which leaves the reader won-
dering what has been achieved over the
last 2 or 3 years.
(i) The Action Plan refers to The Expert Pa-
tient: A New Approach to Disease Man-
agement for the Twenty-First Century.
The website is www.doh.gov.uk/cmo/ep-
report.pdf.21 This is another example of
general good practice being advocated by
the Government. It refers to the amount of
expertise patients have on particular dis-
eases or disorders. The Action Plan states:
‘‘We will look at the feasibility of develop-
ing a disease-speciﬁc module for epilepsy in
the next phase of this work’’. It should be
noted that the wording is again hardly em-
phatic. The Action Plan does not undertake
to provide a module for epilepsy but only
to ‘‘look at the feasibility’’. Incidentally,
it is inappropriate to suggest that epilepsy
is a disease; it is a disorder that may re-
sult from a number of identiﬁable diseases
but usually is the result of no identiﬁable
disease. The report covers some important
issues relating to epilepsy. For example,
‘‘up to 20% of epilepsy patients may be
misdiagnosed and receive inappropriate
and unnecessary treatment’’.
IV. Information provision
(8) This section of the document is preceded by a
paragraph from the audit.
‘‘The audit found deﬁciencies in commu-
nication between health care professionals,
patients, their carers and families. There was
little evidence that epilepsy management and
hazards, such as the risk of death, had been
discussed with patients, their families and car-
ers by any health care professional in primary
or secondary care.’’
(a) At this point in the Action Plan, some
speciﬁc recommendations are made. The
Department of Health undertakes to pro-
vide information by working with epilepsy
voluntary organisations to produce an in-
formation leaﬂet on epilepsy, particularly
around managing risks of the condition.
The voluntary epilepsy agencies, while wel-
coming such co-operation, expressed some
surprise at the implication that literature
was lacking in view of the fact that some
of them produce extensive patient leaﬂets,
which provide much information on the
condition. However, working together with
Government on providing information is
certainly to be encouraged because it is
very clear that neither professionals nor
the general public have the information on
epilepsy that they require. The Action Plan
undertakes to provide resources for this
work in the ﬁnancial year 2003/2004.
(b) One of the few deﬁnite actions taken in this
‘‘Action Plan’’ is to provide £288,600 to the
National Society for Epilepsy to expand its
epilepsy information network. The aim will
be to provide improved information and
support to epilepsy patients and their fam-
ilies. This is to be welcomed. However, it
perhaps highlights one of the difﬁculties in
organising epilepsy services within the UK,
namely the fragmentation of the voluntary
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organisation. An attempt has been made to
overcome this fragmentation by the Joint
Epilepsy Council. There is no doubt about
the excellence of the work of the National
Society for Epilepsy but the reader is left
wondering why some resources to improve
information were not given to the joint
organisation.
(c) The Department of Health undertakes to
improve the provision of information by
‘‘suggesting that NHS Direct Online review
and update the epilepsy information in its
encyclopaedia regularly’’. No-one would
argue against this. However, such updating
should, in any case, form an essential part
of NHS Direct, which is intended to be the
ﬁrst point for providing information to the
public about any medical condition. Those
outside the UK may not be aware of the
role of NHS Direct. This provides telephone
information to the general public on any
medical situation. It is widely thought that
the aim of NHS Direct was to try to reduce
the number of unnecessary calls to gen-
eral practitioners. NHS Direct Online is the
web-based arm of this service. The web-
site is www.nhsdirect.nhs.uk.22 The section
on epilepsy in the encyclopaedia provides
some useful information but certainly could
be improved.
(d) This section refers to: ‘‘Taking advan-
tage of a NHS Direct Online and Medicines
Partnership Task Force project improving
medicines information for patients’’. It is
stated that this will result in the devel-
opment of clear information on medicines
for conditions including epilepsy. The
current NHS Direct Online encyclopae-
dia could be improved in this regard and
any initiative to undertake this would be
worthwhile.
(e) The Action Plan refers to copying letters to
patients. Many physicians already do this.
It is to be encouraged.
(f) This section states that information will
be improved by engaging with the Royal
Colleges to raise awareness of the audit
(on epilepsy-related death), particularly
highlighting the issue of informing patients
about epilepsy management and the risks
associated with their condition. Again, this
is a rather vague statement but it is, nev-
ertheless, welcomed.
The Action Plan lists a number of epilepsy or-
ganisations with websites and telephone num-
bers. This information is very useful, although
the list is by no means complete.
What form should an Action Plan take?
In putting forward the following model Action Plan,
the current author is not suggesting that it will be
perfect nor that it will be the ﬁnal word. On the
contrary, the model is meant to provide a stimulus
to the discussions on how to implement the neces-
sary changes in epilepsy services that are so long
overdue.
It is also acknowledged that current government
policy is to devolve decision-making down to the
local level. For conditions that involve hundreds of
thousands of people, such as epilepsy, many in the
ﬁeld would maintain that a national plan is very
much needed and that this should avoid the inefﬁ-
ciency of having to ‘‘re-invent the wheel’’ in sepa-
rate local policies throughout the country.
In the opinion of the present author, an Action
Plan should be clearly set out and easy to follow.
It should be in a standardised format that allows
rapid reference to the issue, the solution and the
proposed outcome measures. In the light of issues
raised earlier in this paper, the following format is
suggested.
Suggested format for 10-point model
Action Plan
Issue 1
Providing adequate training for professionals in
health care, other relevant caring professionals
and teachers.
Current situation
Knowledge about epilepsy is poor among profession-
als generally.
Solution
Each profession will devise a body of ‘‘core
knowledge’’ required by members of the profession
about epilepsy. This will be achieved by represen-
tatives from the profession meeting with the Joint
Epilepsy Council and a suitable tertiary educational
body. The ‘‘core knowledge’’ will be incorporated
into the training courses for each professional dis-
cipline. Individuals will be examined/assessed on
this knowledge to ensure that an adequate standard
has been reached before they earn their qualiﬁca-
tion. For professionals who are already qualiﬁed, a
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requirement of their continuing professional devel-
opment will be that they have acquired the agreed
standard of ‘‘core knowledge’’.
Outcome measures, targets and timescale
A pass rate of at least 90% in the epilepsy module
of those gaining a professional qualiﬁcation.
At least 20% of those who have already qual-
iﬁed will attend continuing professional develop-
ment courses on the ‘‘core knowledge’’ per year.
Issue 2
Educating the public.
Current situation
Ignorance about epilepsy leads to fear of the con-
dition, increasing stigma. This greatly impairs the
quality of life of people with epilepsy and their fam-
ilies.
Solution
All schools will include an epilepsy module in their
health education curriculum. The details of the
module will be agreed between the Department of
Education, the Joint Epilepsy Council and repre-
sentatives from the teaching profession/schools.
Information on these teaching modules will also be
available on the web. Children will be encouraged
not only to discuss the information with teachers
but also to share and discuss the information with
their parents.
Outcome measures, targets and timescale
The educational package for schools will be imple-
mented within 2 years. This implies that all chil-
dren attending school will have had education on
epilepsy within 3 years.
Issue 3
Providing the patient with clear and full information
on epilepsy, treatment and risks.
Current situation
Good information leaﬂets are available on seizure
types, epilepsy types, treatment, pregnancy and
risks, including the risk of drowning in the bath and
the risk of SUDEP. However, this information is of-
ten not provided to newly-diagnosed patients and
many of those who have well-established epilepsy
have never had access to it.
Solution
Provide all patients with epilepsy with a suitable
series of information leaﬂets, targeted to the pa-
tient. Although the voluntary organisations produce
good leaﬂets, these should be merged, under the
umbrella of the Joint Epilepsy Council, and should
be scrutinised by the Department of Health before
being made available to all general practitioners for
this purpose. The leaﬂets will provide a list of the
key sources of help and information, including con-
tact details for the major voluntary epilepsy organ-
isations and ‘‘Epilepsy Bereaved?’’ Some general
practices may prefer to print this documentation
off the web whereas others may prefer to have it in
hard copy, provided by the Department of Health.
Outcomes measures, targets and timescale
The Joint Epilepsy Council will provide the neces-
sary documentation agreed by the Department of
Health within 18 months and will be given the nec-
essary resources to achieve this. Within the follow-
ing 12 months general practitioners will be required
to provide all newly-diagnosed patients with the
relevant information sheets. Within the ensuing 12
months all GPs will be required to write to each
patient with epilepsy offering information as hard
copy and indicating where the information leaﬂets
can be viewed on the web. The information will in-
dicate when it is likely that specialist referral will
be required and how to obtain such referral through
the general practitioner.
Issue 4
Improving the quality of diagnosis.
Current situation
Various studies on the accuracy of diagnosis by the
medical profession have indicated that the rate of
misdiagnosis is of the order of 25%.
Solution
As part of the initiative above ‘‘providing ad-
equate training for professionals’’ all medical
schools and nurse training courses will be required
to provide adequate ‘‘core knowledge’’ teaching
to medical students and nurses about the diag-
nosis and management of epilepsy. All relevant
Royal Colleges will be asked to incorporate assess-
ment of ‘‘core knowledge’’ of epilepsy at post-
graduate level in their assessments/examinations.
Web-based continuing professional development
modules on epilepsy, incorporating both training
and self-assessment, will be developed for doc-
tors/nurses in training and for those that are al-
ready qualiﬁed.
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Outcome measures, targets and timescale
Core knowledge for medical students and nurses
will be determined by the Department of Health in
consultation with the appropriate agencies within
18 months. All medical schools and nurse teach-
ing establishments will incorporate the agreed core
knowledge about epilepsy into their curricula within
the following 2 years.
It will be a requirement of continuing professional
development of all practising doctors that they ac-
quire a speciﬁed level of knowledge about epilepsy
within 5 years, either by attending speciﬁed courses
or by completing a web-based continuing profes-
sional development module on epilepsy.
Issue 5
Providing adequate targeted investigation and
treatment, including treatment of status epilepti-
cus.
Current situation
There is generally poor knowledge of what inves-
tigations and treatment are appropriate for spe-
ciﬁc types of epilepsy. Delays in treatment of status
epilepticus may result in permanent brain damage
or death.
Solution
Speciﬁc guidelines for investigation and treatment
will be provided by the Joint Epilepsy Council, in
consultation with the Royal Colleges and the Na-
tional Institute for Clinical Excellence.
Outcome measures, targets and timescale
The guidelines will be produced within 2 years. The
degree to which the guidelines are followed will be
audited within a further 2 years of their publication.
The audit results will be used to inform Government
about necessary changes that may be required in
the guidelines or their implementation.
Issue 6
Support for the psychological wellbeing of patients
and families.
Current situation
Although there is increasing awareness of the
wide-ranging effects of epilepsy on individuals and
their families, there is still a tendency, among some
professionals, to imagine that treating the seizures
is the only issue.
Solution
The epilepsy voluntary organisations, including
Epilepsy Action (British Epilepsy Association) and
the National Society for Epilepsy will, through the
umbrella organisation of the Joint Epilepsy Council,
co-opting other parties as necessary, make speciﬁc
recommendations to central Government for ad-
dressing these issues, drawing on both positive and
negative experiences of their members. Appropri-
ate resources for this project will be provided.
Outcome measures, targets and timescale
The report and recommendations will be produced
within 18 months. Agreement with Government de-
partments will be achieved within 1 year of publi-
cation of the report and the ﬁndings will be imple-
mented within the following 2 years.
Issue 7
Making available expert attention for special groups
such as children, women of childbearing age, preg-
nant women, the elderly and people with learning
disability or psychiatric disturbance.
Current situation
Services for these special groups are particularly
patchy at present. There is a lack of good models
of service.
Solution
The Department of Health will be responsible for
drawing together working groups for each of these
special groups of patients.
Outcome measures, targets and timescale
The working groups will report within 12 months
with speciﬁc recommendations for addressing the
needs of each special group. Implementation of ap-
propriate measures will be agreed with the Depart-
ment of Health within 12 months of these reports.
The situation will be audited within the following
2 years to assess whether the needs of each group
have been met adequately.
Issue 8
Providing adequate epilepsy neurosurgery services
for both adults and children.
Current situation
It is estimated that there are 380,000 people with
epilepsy in the UK, of whom perhaps 30% have
uncontrolled epilepsy. Of this 30% (114,000) it is
estimated that around 4,500 might beneﬁt from
neurosurgery. The current capacity for epilepsy
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neurosurgery would only cope with a tiny frac-
tion of this number. Furthermore, there are very
few centres that adequately staffed and set up
to manage young people undergoing neurosurgery,
although it has been suggested that the earlier
surgery is performed the better the outcome.
Solution
The current situation will be audited with attention
both to the overall resources available and the ge-
ographical location of resources. The audit will in-
clude gathering of information on epilepsy surgery
facilities for children and teenagers. Recommenda-
tions will be based on the outcome of this audit.
This information will inform planners so that they
are able to advise on the number of people who will
need to train as epilepsy neurosurgeons and as other
members of the multidisciplinary team, to make up
the shortfall.
Outcome measures, targets and timescale
Because it is anticipated that the audit will show
that there is a major shortfall in epilepsy neuro-
surgery both for adults and children, it will proba-
bly take decades to make up the shortfall. Because
the time required to train surgeons and other staff
in this speciality is considerable, a realistic target
would probably be to decrease the shortfall by 25%
in 10 years and by 50% in 15 years. A tertiary centre
capable of providing epilepsy neurosurgery should
generally be available within a reasonable distance
(e.g. 100 miles or 2 h travel) of all major population
areas within the UK within the next 5 years.
Issue 9
Setting clear standards for epilepsy services, using
limited resources to best advantage and establish-
ing good resource planning.
Current situation
The best delivery of epilepsy services is almost
certainly through multidisciplinary teams, making
full use of epilepsy liaison nurses. The role of the
epilepsy liaison nurse has increased in a major way
over recent years but such services are by no means
uniformly provided. This implies that expensive
consultant time is used in an inefﬁcient manner to
fulﬁl needs that, in some cases, could be better
fulﬁlled by specially trained nurses.
Solution
Models of best practice of multidisciplinary deliv-
ery of epilepsy services will be re-examined, with
particular attention to efﬁcient use of resources.
Use of resources will be audited against these mod-
els in three or four randomly-selected areas of the
country and recommendations will be made on the
basis of this audit.
Outcome measures, targets and timescales
Each tertiary service will have at least one epilepsy
liaison nurse within 5 years of the audit. Speciﬁc
planning for addressing geographical and different
ethnic/social class inequalities will be produced
within 2 years and will be implemented in a step-
wise fashion over the ensuing 10 years.
Issue 10
Ensuring that there are good epilepsy services
throughout the country instead of the current
patchy provision.
Current situation
There are inequalities of provision across geo-
graphical areas and across different ethnic/social
class groups. There are few centres of excellence
for epilepsy services in the UK. Specialist epilepsy
services between these areas vary from good to
non-existent. This implies that a patient with prob-
lematic epilepsy may need to wait for a long time
and travel a long distance to obtain the service
they need.
Solution
The present service will be audited in 10 randomly-
chosen areas of the country and the service pro-
vided will be assessed against knownmodels of good
service. The audit will be led by the Department
of Health. The form of the audit will be devised
by this department in close consultation with rep-
resentatives from the Joint Epilepsy Council, two
acknowledged centres of excellence and patient
representatives. The results of the audit will be
used for workforce planning to rectify the inequal-
ities and shortfalls in service over the country.
Outcome measures, targets and timescales
The audit will be devised in 1 year and completed
in the following year. Within 18 months of the com-
pletion of the audit, a plan will be produced to
address the workforce implications, geographical,
social and ethnic inequalities, and any shortfall in
other resources. The target will be to rectify at least
50% of the shortfall and inequalities within 10 years
of the plan and at least 90% in 15 years.
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Comment on the model Action Plan
Although the current author takes full responsibil-
ity for the suggested 10-point model Action Plan,
the information on which it is based is available in
a series of good reports produced over the years.
In this context, particular attention should again
be drawn to the Scottish Intercollegiate Guidelines
Network document Diagnosis and Management of
Epilepsy in Adults–—A National Clinical Guideline
(April 2003),13 the Joint Epilepsy Council National
Statement of Good Practice for the Treatment and
Care of People who have Epilepsy12 and a number
of previous documents.23—27
There are, no doubt, considerable gaps in the sug-
gested Action Plan provided by the current author.
However, this should only serve to strengthen the
case for involving agencies fully in the development
of any Action Plan adopted by government. It is a
great credit to the Department of Health that agen-
cies such as Epilepsy Action (the British Epilepsy As-
sociation), the Joint Epilepsy Council and Epilepsy
Bereaved? were consulted. However, from the re-
sponse made by some of these agencies to the Plan,
it could be argued that a more complete consulta-
tion process is still required.
Conclusions
Both the Government and the Chief Medical Ofﬁ-
cer are to be congratulated for having put epilepsy
services on the health agenda. It is also impor-
tant to see this document in context. Worldwide,
most people with epilepsy have no access to treat-
ment whatever and the treatment gap (those
with epilepsy who have no access to antiepilep-
tic medication) is over 90% in some areas of the
world.28 At least everyone in the UK has access
to antiepileptic drugs. How does this government
initiative compare with those in other countries of
the western world? Although some countries have
well-organised epilepsy services, most do not. Some
of the most ‘‘developed’’ countries in the world
would be jealous of people in the UK who have
a government that considers these issues worthy
of attention and debate. Although approximately
380,000 people in the UK are said to have epilepsy
it would be quite wrong to suggest that this is the
number of people affected by the condition. Most
people with epilepsy have families. The presence
of a member of the family with epilepsy can have
a profound effect on the rest of the family. In this
sense, epilepsy probably affects well over a million
people in the UK, although only a third of this num-
ber actually have the condition. There seems to
be general consensus that the provision of epilepsy
services has been inadequate. This has been high-
lighted by the audit on epilepsy-related deaths
and has been acknowledged in the excellent report
of the Chief Medical Ofﬁcer.3 The Department of
Health has produced an Action Plan.4 It should,
more properly, perhaps have been called an interim
plan. Those who have a particular interest in man-
aging epilepsy have, on the whole, had a similar
reaction to the document. It is an important ﬁrst
step, and for that everyone is grateful. However,
reaching a destination generally requires more than
a ﬁrst step and unless this document is followed up
by a number of speciﬁc undertakings with measur-
able outcomes, targets and timescales, it may fall
into the category of being yet another interesting
document that has little or no effect on the quality
or availability of services for people with epilepsy.
We very much hope that the Department of Health
will not falter in taking the necessary further steps
to achieve the ultimate goal of providing good and
effective services for people with epilepsy.
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